Aescuvest
Aescuvest is a Frankfurt-based venture capital firm founded in 2014, specializing in the healthcare sector. As a leading pan-European FinTech entity, it focuses on providing next-generation venture capital through an innovative digital platform. Aescuvest has established a prestigious partnership with EIT Health, granting it exclusive access to top ventures in the rapidly growing healthcare market. The firm's mission is to facilitate meaningful investments in medical innovations that enhance patient care. As the first pan-European digital venture capital platform in the healthcare space, Aescuvest aims to shape the future of health in Europe by supporting high-potential startups with both capital and expertise. By utilizing a Special Purpose Vehicle (SPV) structure, Aescuvest offers unique investment opportunities to a diverse range of investors, including venture capitalists, family offices, business angels, and high-net-worth individuals.
XO Life operates a digital patient monitoring platform focused on gathering real-world evidence to enhance patient insights regarding medications and therapies. Collaborating with the PROMIS Institute Germany, a prominent research organization in patient-centered studies, XO Life aims to systematically record patient experiences across various diseases. The platform allows patients to independently document their therapy journeys and outcomes, providing scientifically validated insights that can be utilized by the life sciences industry and healthcare professionals. By offering patient companionship as a service to pharmaceutical and medical technology companies, XO Life seeks to improve patient engagement, adherence, and overall satisfaction with treatments, ultimately fostering a better connection between patients and manufacturers.
MEDIKURA Digital Health GmbH, founded in 2017 and based in Munich, Germany, specializes in developing a platform focused on drug safety issues and analysis. The company offers a suite of products, including MEDIKURA Capture, which allows users to report side effects online; MEDIKURA Insights, which provides insights into drug safety and customer satisfaction; and MEDIKURA Guide, designed to help users understand the risks and benefits of their medications. Catering primarily to the pharmaceutical and insurance industries, MEDIKURA aims to enhance drug safety and improve the overall understanding of medication-related risks.
Equity Crowdfunding in 2020
Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative smart glass technology aimed at enhancing mobility for individuals with disabilities. The company’s flagship product, munevo DRIVE, is a Smartglass application that allows users to control electric wheelchairs through head movements, translating these motions into digital signals for hands-free operation. This technology enables users to navigate both indoor and outdoor environments independently. In addition to the software, Munevo also provides various adaptors and accessories to complement its solutions, further supporting individuals with mobility impairments in achieving greater autonomy.
Equity Crowdfunding in 2020
Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative smart glass technology aimed at enhancing mobility for individuals with disabilities. The company’s flagship product, munevo DRIVE, is a Smartglass application that allows users to control electric wheelchairs through head movements, translating these motions into digital signals for hands-free operation. This technology enables users to navigate both indoor and outdoor environments independently. In addition to the software, Munevo also provides various adaptors and accessories to complement its solutions, further supporting individuals with mobility impairments in achieving greater autonomy.
Equity Crowdfunding in 2020
Emperra GmbH E-Health Technologies, founded in 2008 and based in Potsdam, Germany, specializes in the development of telemedical products aimed at managing diabetes. The company focuses on GSM and web-based solutions that facilitate the tracking, monitoring, and transmission of crucial diagnostic and therapeutic data for diabetic patients, including insulin doses, blood sugar levels, and carbohydrate intake. Emperra's innovative diabetes monitoring system integrates a Bluetooth-enabled insulin pen and a wireless blood glucose meter, allowing healthcare professionals to effectively monitor their patients' conditions and adjust treatments as necessary.
Equity Crowdfunding in 2020
BOCAhealth is a patented portable device (connected to an app) that is able to measure and keep track of the hydration status of a user without the need for medical personnel.
Equity Crowdfunding in 2019
Developer of steerable, detachable, and cleanable minimally invasive instruments designed for arthroscopy and laparoscopy. The company's instruments allow extreme instrument reachability, easy cleaning, and improved procedures in surgery, providing surgeons with better access to surgical areas.
Equity Crowdfunding in 2018
VisionHealth GmbH is a Munich-based company that specializes in developing healthcare software solutions for patients suffering from various respiratory diseases. Founded in 2017, VisionHealth has created a product named Kata, which enhances inhalation therapy for individuals with chronic lung conditions such as asthma and COPD. This digital solution connects patients with medical staff and offers training to ensure effective inhaler use, ultimately helping to reduce instances of shortness of breath and the need for hospitalizations. Kata utilizes artificial intelligence and machine learning to recognize inhalers and interpret user movements, thereby improving the management of inhalation therapy for patients.
Equity Crowdfunding in 2017
MOIO GmbH, founded in 2017 and based in Fürth, Germany, specializes in digital health solutions with its flagship product, the moio.care system. This innovative system features a sensor-based patch that users wear directly on their skin, available in various attachment options. It tracks user movements and provides critical information through a mobile application, allowing caregivers to monitor patients effectively. The device can trigger alarms if a disoriented individual leaves a specified area and is capable of detecting falls, promptly notifying caregivers of the patient's location. This functionality aids in delivering timely assistance while enhancing comfort for the user. MOIO GmbH collaborates with research and industry partners to continuously improve and expand its offerings in the healthcare market.
Equity Crowdfunding in 2017
Rodos BioTarget GmbH is a biopharmaceutical company based in Hanover, Germany, founded in 2008. The company specializes in developing advanced drug delivery technologies, notably its patented TargoSphere platform. This nanocarrier system is designed to deliver a variety of therapeutic agents directly to antigen-presenting cells, thereby enhancing the immune response against infectious diseases caused by viruses, such as Hepatitis C and HIV, as well as bacterial infections like Tuberculosis and MRSA. Rodos BioTarget also offers TargoBiotics, which includes antibiotics for intracellular treatment, and TargoVir for viral infections. Additionally, the TargoSphere technology has potential applications in managing chronic inflammation, cancer, allergies, and autoimmune diseases by addressing imbalances in immune responses. The company's innovations aim to improve drug stability, biodistribution, and therapeutic efficacy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.